These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 6433908

  • 1. Metabolism of valproic acid by hepatic microsomal cytochrome P-450.
    Prickett KS, Baillie TA.
    Biochem Biophys Res Commun; 1984 Aug 16; 122(3):1166-73. PubMed ID: 6433908
    [Abstract] [Full Text] [Related]

  • 2. Oxidation and glucuronidation of valproic acid in male rats--influence of phenobarbital, 3-methylcholanthrene, beta-naphthoflavone and clofibrate.
    Heinemeyer G, Nau H, Hildebrandt AG, Roots I.
    Biochem Pharmacol; 1985 Jan 01; 34(1):133-9. PubMed ID: 3917666
    [Abstract] [Full Text] [Related]

  • 3. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes.
    Bolton JL, Thompson JA.
    Drug Metab Dispos; 1991 Jan 01; 19(2):467-72. PubMed ID: 1676656
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM, van de Straat R, Groeneveld M, Vermeulen NP.
    Xenobiotica; 1990 Sep 01; 20(9):967-78. PubMed ID: 2122607
    [Abstract] [Full Text] [Related]

  • 6. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies.
    Rettie AE, Boberg M, Rettenmeier AW, Baillie TA.
    J Biol Chem; 1988 Sep 25; 263(27):13733-8. PubMed ID: 3138238
    [Abstract] [Full Text] [Related]

  • 7. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
    Okita RT, Masters BS.
    Drug Metab Dispos; 1980 Sep 25; 8(3):147-51. PubMed ID: 6104577
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
    Vyas KP, Kari PH, Prakash SR, Duggan DE.
    Drug Metab Dispos; 1990 Sep 25; 18(2):218-22. PubMed ID: 1971576
    [Abstract] [Full Text] [Related]

  • 10. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D, Decker RW, Ritter CL, Polovina MR.
    Carcinogenesis; 1985 Jan 25; 6(1):95-103. PubMed ID: 3967341
    [Abstract] [Full Text] [Related]

  • 11. Mixed-function oxygenation of the lower fatty acyl residues. II. The kinetics of microsomal omega- and (omega - 1)-hydroxylation of N-(4-chlorophenyl)propanamide.
    Apostolescu V, Lenk W.
    Drug Metab Dispos; 1981 Jan 25; 9(4):315-21. PubMed ID: 6114829
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamine.
    Malejka-Giganti D, Magat WJ, Decker RW.
    Xenobiotica; 1989 Apr 25; 19(4):431-44. PubMed ID: 2501941
    [Abstract] [Full Text] [Related]

  • 14. The effect of substrates and inhibitors of cytochrome P-450 on the NADPH inhibition of the ATP-dependent, hepatic, microsomal calcium pump.
    Srivastava SP, Chen NQ, Holtzman JL.
    FEBS Lett; 1990 Dec 10; 276(1-2):135-7. PubMed ID: 2148293
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K, Baillie TA.
    Drug Metab Dispos; 1993 Dec 10; 21(2):242-8. PubMed ID: 8097692
    [Abstract] [Full Text] [Related]

  • 17. Metyrapone - reduced cytochrome P-450 complex: a specific method for the determination of the phenobarbital inducible form of rat hepatic microsomal cytochrome P-450.
    Luu-The V, Cumps J, Dumont P.
    Biochem Biophys Res Commun; 1980 Apr 14; 93(3):776-81. PubMed ID: 7387674
    [No Abstract] [Full Text] [Related]

  • 18. Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate.
    Raza H, Levine WG.
    Drug Metab Dispos; 1986 Apr 14; 14(1):19-24. PubMed ID: 2868860
    [Abstract] [Full Text] [Related]

  • 19. The role of cytochrome P-450 in the synthesis of polar metabolites of aldosterone by microsomes of male rat liver.
    Latif SA, McDermott MJ, Morris DJ.
    Steroids; 1981 Sep 14; 38(3):307-19. PubMed ID: 7303036
    [Abstract] [Full Text] [Related]

  • 20. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V, Schnabel KH.
    Drug Metab Dispos; 1973 Sep 14; 1(1):176-83. PubMed ID: 4149380
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.